Caribou Biosciences (CRBU) Capital Expenditures Growth (3y) (2023 - 2025)
Caribou Biosciences (CRBU) Capital Expenditures Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.60 Bn | 466.80 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.71 Bn | 114.46 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.83 Bn | 61.07 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn | 16.27% |
| 10 | Caribou Biosciences | 155.30 Mn | 37.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 60.38% |
| Sep 30, 2025 | 3.66% |
| Jun 30, 2025 | -33.37% |
| Mar 31, 2025 | 12.96% |
| Dec 31, 2024 | 34.48% |
| Sep 30, 2024 | 41.48% |
| Jun 30, 2024 | -66.67% |
| Mar 31, 2024 | 303.75% |
| Dec 31, 2023 | 117.44% |
| Sep 30, 2023 | 597.56% |